Chicago, IL, United States of America

David Schaller

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Schaller: Innovator in Event Status Indication Technology

Introduction

David Schaller, an inventive mind based in Chicago, IL, has made significant contributions to technology with his unique invention focusing on event status apparatuses. With a single patent to his name, Schaller's work is particularly relevant in the field of healthcare, where it has the potential to enhance user experience in the administration of medications.

Latest Patents

David Schaller holds a patent for "Event status apparatuses and related devices, systems, and methods." This innovative patent encompasses devices that signal the status of various events, including the count of remaining and previously occurred events. The invention is especially valuable for medicament dispensers, such as metered dose inhalers, providing a visual representation of doses administered and those still available for use.

Career Highlights

Currently employed at Lupin, Inc., David Schaller works alongside a talented team of professionals, which includes his colleagues Imran Shaikh and Mukul Dalvi. His role at Lupin, a well-regarded company in the pharmaceutical industry, allows him to be at the forefront of developing technologies that bridge the gap between innovation and practical healthcare applications.

Collaborations

Collaboration plays a vital role in Schaller's career, and his partnerships with Imran Shaikh and Mukul Dalvi reflect a commitment to advancing their collective goal of improving medical devices. Their combined expertise fosters an environment of innovation, ensuring that the products developed cater to both healthcare practitioners and patients.

Conclusion

David Schaller's contributions to event status indication technology showcase the importance of innovation in healthcare. With his patent, he is paving the way for improved administration of medications, reinforcing the role of inventors in developing solutions that enhance patient experiences. As Schaller continues his work at Lupin, the future looks promising for further advancements that can redefine medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…